Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

Clinical trial NCT00911443 · COMPLETED

Trial details

NCT number: NCT00911443
Sponsor: sigma-tau i.f.r. S.p.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2002-07-01
Primary completion: 2007-09-01
Enrollment: 488

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.